¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cell cycle restriction point"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • disparate point
    ºñ´ëÀÀÁ¡
  • exclamation point hair
    °¨ÅººÎÈ£ÅÐ
  • focal point
    ÃÊÁ¡
  • freezing point
    ¾î´ÂÁ¡, ºùÁ¡
  • freezing point depression
    ¾î´ÂÁ¡°­ÇÏ, ºùÁ¡°­ÇÏ
  • far point
    ¿øÁ¡
  • gingival point angle
    ÀÕ¸ö¸ð¼­¸®°¢
  • jugomaxillary point
    ±¤´ë¾Õ¾Æ·¡Á¡, Çù»ó¾ÇÁ¡
  • leaking point
    »ùÁ¡, ´©ÃâÁ¡
  • leak-point pressure
    ´©ÃâÁ¡¾Ð
  • lacrimal point
    ´«¹°Á¡
  • malar point
    ±¤´ëÁ¡
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • motor point
    ¿îµ¿Á¡
  • McBurney¡¯s point
    ¸Æ¹ö´ÏÁ¡
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • scavenger cell
    û¼Ò¼¼Æ÷
  • Schwann's cell
    ½Å°æÁý¼¼Æ÷
  • signet ring cell carcinoma
    ¹ÝÁö¼¼Æ÷¾ÏÁ¾
  • signet-ring cell
    ¹ÝÁö¼¼Æ÷
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • spindle cell
    ¹æÃß¼¼Æ÷
  • squamous cell carcinoma
    ÆíÆò¼¼Æ÷¾ÏÁ¾
  • squamous cell in situ carcinoma
    ÆíÆò¼¼Æ÷»óÇdz»¾ÏÁ¾, ÆíÆò¼¼Æ÷¾ÏÁ¾
  • stellate cell
    º°¼¼Æ÷
  • stem cell
    Áٱ⼼Æ÷
  • supporting cell
    ¹öÆÀ¼¼Æ÷
  • sustentacular cell
    (¢¡supporting cell) ¹öÆÀ¼¼Æ÷
  • target cell
    Ç¥Àû¼¼Æ÷
  • transitional cell
    ÀÌÇ༼Æ÷
  • transitional cell carcinoma
    ÀÌÇ༼Æ÷¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • cut-off point
    °áÁ¤Á¡
  • point charge
    Á¡ÇÏÀü
  • three point balancing contact
    »ïÁ¡Á¢Ã˱³ÇÕ
  • disparate point
    ºñ´ëÀÀÁ¡
  • freezing point depression
    ¾î´ÂÁ¡°­ÇÏ
  • point discharge
    Á¡¹æÀü
  • two point discrimination
    µÎÁ¡½Äº°
  • end-point nystagmus
    ±ØÀ§´«¶³¸², ±ØÀ§¾ÈÁø
  • exclamation point hair
    °¨ÅººÎÈ£ÅÐ
  • point estimation
    Á¡ÃßÁ¤¹ý
  • point source epidemic
    ´ÜÀϰ¨¿°¿øÀ¯Çà
  • far point
    ¿øÁ¡
  • focal point
    ÃÊÁ¡
  • freezing point
    ¾î´ÂÁ¡, ºùÁ¡
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • point outside field
    Á¶»ç¿µ¿ª¹ÛÁöÁ¡
  • point prevalence
    ½ÃÁ¡À¯º´¼ö(ËàËøËôËÓ ).
  • point sampling
    Á¡ÃßÃâ¹ý(ËøÌ§Ì§ËÑ).
  • point under block
    ºí·ÏÇÏÁöÁ¡
  • point ³ª puntcum
    Á¡(ïÇ).
  • posterior focal point
    ÈÄÃÊÁ¡(ý­õ¥ïÇ).
  • pressure point
    ¾Ð¹ÚºÎÀ§(¡­Ý»êÈ), ¾ÐÅëÁ¡ (¡­ïÇ).
  • pressure point
    ¾Ð¹ÚºÎÀ§(äâÚÞÝ»êÈ), ¾ÐÅëÁ¡(äâ÷ÔïÇ)
  • primary focal point
    Á¦ÀÏÃÊÁ¡
  • principal point
    ÁÖÁ¡(ñ«ïÇ) ½ÃÃà(ãÊõî)ÀÇ .
  • principal point
    ÁÖÁ¡
  • radiant point
    ¹æ»çÁ¡
  • range of point
    ¿­Á¡(æïïÇ).
  • reference point
    ±âÁØÁ¡
  • reflection point
    ¹Ý»çÁ¡(ÚãÞÒïÇ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • developmental cycle
    ¹ßÀ°ÁÖ±â
  • diurnal cycle
    ÁÖ°£ÁÖ±â(ñ¸ÊàñÎÑ¢)
  • duty cycle
    µ¿ÀÛ ºñÀ²
  • endometrial cycle
    Àڱ󻸷ÁÖ±â.
  • endometrial cycle
    Àڱ󻸷ÁÖ±â(í­ÏàҮدñÎÑ¢).
  • epidemic cycle
    À¯Çà¼øÈ¯.
  • erythrocytic cycle
    ÀûÇ÷±¸¹ßÀ°È¯.±â»ýÀû³»¹ßÀ°È¯.
  • estrous cycle
    ¹ßÁ¤ÁÖ±â(¡­ñÎÑ¢).
  • estrous cycle
    ¹ßÁ¤ÁÖ±â
  • estrus cycle
    ¹ßÁ¤ÁÖ±â(¡­ñÎÑ¢).
  • female reproductive cycle
    ¿©¼º»ý½ÄÁÖ±â
  • gastric cycle
    À§ÁÖ±â(êÖñÎÑ¢).
  • genesial cycle
    ¿©ÀÚ»ý½ÄÁÖ±â.
  • glucose lactate cycle
    ±Û·çÄÚ¿À½º¶ôÆ®»ê ȸ·Î.
  • gravitational cycle
    ÀÓ½ÅÁÖ±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Microvillous epithelial cell
    ¹Ì¼¼À¶¸ð»óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¹Ì¼¼À¶¸ð»óÇǼ¼Æ÷
  • Microvillous cuboidal mesothelial cell
    ¹Ì¼¼À¶¸ðÀÔ¹æÁßÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¹Ì¼¼À¶¸ðÀÔ¹æÁßÇǼ¼Æ÷
  • Microplica epithelial cell
    ¹Ì¼¼ÁÖ¸§»óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¹Ì¼¼ÁÖ¸§»óÇǼ¼Æ÷
  • Nonfenestrated endothelial cell
    ¹Îâ³»ÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¹«Ã¢³»ÇǼ¼Æ÷
  • Basket cell
    ¹Ù±¸´Ï¼¼Æ÷
    [¿¾ ¿ë¾î] ³ó¼¼Æ÷
  • Outer pillar cell
    ¹Ù±ù±âµÕ¼¼Æ÷
    [¿¾ ¿ë¾î] ¿ÜÁÖ¼¼Æ÷
  • Outer sustentacular cell
    ¹Ù±ù¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ¿ÜÁöÁÖ¼¼Æ÷
  • Outer phalangeal cell of Deiters
    ¹Ù±ù¼Õ°¡¶ô¼¼Æ÷
    [¿¾ ¿ë¾î] ¿ÜÁö»ó¼¼Æ÷
  • Outer hair cell
    ¹Ù±ùÅм¼Æ÷
    [¿¾ ¿ë¾î] ¿ÜÀ¯¸ð¼¼Æ÷
  • Basal epithelial cell
    ¹Ù´Ú»óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ±âÀúÃþ»óÇǼ¼Æ÷
  • Basal cell
    ¹Ù´Ú¼¼Æ÷
    [¿¾ ¿ë¾î] ±âÀú¼¼Æ÷
  • Fusiform myoepithelial cell
    ¹æÃß±ÙÀ°»óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¹æÃß»ó±Ù»óÇǼ¼Æ÷
  • Fusiform endothelial cell
    ¹æÃß³»ÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¹æÃß»ó³»ÇǼ¼Æ÷
  • Sustentacular cell
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁÖ¼¼Æ÷
  • Parietal cell
    º®¼¼Æ÷
    [¿¾ ¿ë¾î] º®¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • carbon reduction cycle
    ź¼Ò ȯ¿ø ȸ·Î(÷©áÈü½êªüÞÖØ)
  • citrate cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • citrate-pyruvate cycle
    ½ÃÆ®¸£»ê(ß«)-ÇǸ£ºê»êȸ·Î(ß«üÞÖØ)
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • Cori cycle
    ÄÚ¸® ȸ·Î(üÞÖØ)
  • cycle
    "°í¸®, ȸ·Î(üÞÖØ), ȯ»ó(ü»ßÒ)"
  • dicarboxylic acid cycle
    "ÀÌ(ì£)Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ), (ÔÒ) glyoxylate cycle"
  • elongation cycle
    ¿¬ÀåÁÖ±â (æÅíþñÎÑ¢)
  • futile cycle
    ¹«ÀÍ È¸·Î(ÙíìÌüÞÖØ)
  • generation cycle
    ¼¼´ë ÁÖ±â(á¦ÓÛñÎÑ¢)
  • glucose-alanine cycle
    ±Û·çÄÚ½º-¾Ë¶ó´Ñ ȸ·Î(üÞÖØ)
  • ¥ã-glutamyl cycle
    ¥ã-±Û·çŸ¹Ð ȸ·Î(üÞÖØ)
  • glycine-allantoin cycle
    ±Û¶óÀ̽Å-¾Ë¶õÅäÀΠȸ·Î(üÞÖØ)
  • glycine-succinate cycle
    ±Û¶óÀ̽Å-¼®½Å»ê(ß«) ȸ·Î(üÞÖØ)
  • glycolic acid cycle
    ±Û¶óÀÌÄÝ»ê(ß«) ȸ·Î(üÞÖØ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • sickle-cell anemia
    °â»ó(Àû)Ç÷±¸¼ººóÇ÷
  • signet-ring cell
    ¹ÝÁö¼¼Æ÷, ÀÎȯ¼¼Æ÷
  • small cell
    ¼Ò¼¼Æ÷
  • small cleaved cell
    ¼ÒºÐÇÒ¼¼Æ÷
  • spindle cell
    ¹æÃ߻󼼯÷
  • squamous cell carcinoma
    ÆíÆò¼¼Æ÷¾ÏÁ¾
  • stem cell
    °£¼¼Æ÷
  • stromal cell
    °£Áú¼¼Æ÷
  • T cell ¡ìthymus derived lymphocyte¡í
    T¼¼Æ÷ ¡ì Èä¼±À¯·¡ ¸²ÇÁ±¸¡í
  • tumor cell
    Á¾¾ç¼¼Æ÷
  • white blood cell
    ¹éÇ÷±¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
BCL basic cycle length; B-cell leukemia/lymphoma
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CCS Canadian Cardiovascular Society; casualty clearing station; cell cycle specific; cholecystosonograph...
CL capillary lumen; cardiolipin; cell line; centralis lateralis; chemiluminescence; chest and left arm ...
DC daily census; data communication; data conversion; decrease; deep compartment; Dental Corps; deoxych...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
HACCP Hazard Analysis Critical Control Point
HACCP Hazard Analysis and Critical Control Point
LPP Leak point pressure
POC Point Of Care
PSF Point Spread Function
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mesio-bucco-occlusal point angle
    ±Ù½É Çù ±³ÇÕ¸é ÷°¢
  • mesiobuccal occlusal point angle
    ±Ù½É ÇùÇÕ¸é ÷°¢
  • motor point
    ¿îµ¿ Á¡
  • muscle trigger point
    ±Ù ¹ßÅëÁ¡
  • myofascial trigger point pain
    ±Ù¸· ¹ßÅëÁ¡ ÅëÁõ, ±Ù¸· ¹ßÅëÁ¡ µ¿Åë
  • near point of accommodation
    Á¶Àý ±ÙÁ¡
  • object point
    ¹°Á¡
  • occipital point
    ÈĵÎÁ¡
    À¯µ¹ ÈÄ¿¬¿¡ ÀÖ´Â ¾ÐÅëÁ¡À¸·Î, ½Å°æ ¼è¾àÀÇ ÇÑ ÁõÈÄ. µÎ°³ ½Ã»ó°æÀÇ ÈÄ´Ü.
  • ossification point
    °ñ È­Á¡
  • painful point
    µ¿ÅëÁ¡
  • physiological zero point
    »ý¸®Àû ¿µÁ¡
  • pin-point bleeding
    ÇÉ ¸Ó¸® Å©±âÀÇ ÃâÇ÷
  • point A
    A Á¡
    X¼±Çп¡ À־ µÎºÎ °èÃøÀÇ ¸ñÇ¥Á¡À¸·Î¼­, µÎºÎ Ãø¸é»ó¿¡¼­ °áÁ¤µÈ´Ù. ÄÚ ¾Õ ³¡À¸·ÎºÎÅÍ »ó¾Ç ÀÍ»ó µ¹±â¸ª¿¡ À̸£´Â ±¸ºÎ·¯Áø °ñ ºÎºÐÀÇ °¡Àå µ¹ÃâÇÑ ºÎºÐÀÌ´Ù.
  • point mode
    Á¡ ¹æ½Ä
  • point of articulation
    Á¶À½Á¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
direct life cycle <epidemiology> A life cycle in which a parasite is transmitted directly from one host to the next without an intermediate host or vector of another species.
(05 Dec 1998)
indirect life cycle <epidemiology> A life cycle which requires one or more intermediate hosts before the definitive host species is reinfected. Compare direct, nondirect.
(05 Dec 1998)
isometric period of cardiac cycle That period in which the muscle fibres do not shorten although the cardiac muscle is excited and the pressure in the ventricles rises, extending from the closure of the atrioventricular valves to the opening of the semilunar valves (isovolumic constriction) or the reverse (isovolumic relaxation).
(05 Mar 2000)
ornithine cycle The metabolic pathway isfound in vertebrates and takes place in theliver, in it, urea is synthesised from amino acids and carbon dioxide.
(09 Oct 1997)
ovarian cycle The normal sex cycle which includes development of an ovarian (graafian) follicle, rupture of the follicle with discharge of the ovum, and formation and regression of a corpus luteum.
(05 Mar 2000)
TCA cycle <biochemistry> The central feaure of oxidative metabolism. Cyclic reactions whereby acetyl CoA is oxidized to carbon dioxide providing reducing equivalents (NADH or FADH2) to power the electron transport chain. Also provides intermediates for biosynthetic processes.
(16 Dec 1997)
thermal conversion cycle <radiobiology> Process of generating electrical power with a fusion reactor by means of a steam / other gas turbine. This is distinct from direct conversion cycles.
(09 Oct 1997)
topping cycle A cogeneration system in which electric power is produced first. The reject heat from power production is then used to produce useful process heat.
(05 Dec 1998)
endogenous cycle The portion of a parasitic life cycle occurring within the host.
(05 Mar 2000)
tricarboxylic acid cycle <biochemistry> The central feaure of oxidative metabolism. Cyclic reactions whereby acetyl CoA is oxidized to carbon dioxide providing reducing equivalents (NADH or FADH2) to power the electron transport chain. Also provides intermediates for biosynthetic processes.
(16 Dec 1997)
estrous cycle The series of physiologic uterine, ovarian, and other changes that occur in higher animals, consisting of proestrus, estrus, postestrus, and anestrus or diestrus.
(05 Mar 2000)
estrus cycle A reproductive cycle in some female mammals (but not female humans, who instead have menstrual cycles). The cycle is characterised by a short period of intense sexual desire (called estrus or heat) when the animal is fertile, which often occurs only once or twice a year, and involves correlating physical changes of the reproductive tract.
(09 Oct 1997)
exoerythrocytic cycle That nonpathogenic portion of the vertebrate phase of the life cycle of malarial organisms that takes place in liver cells, outside of the blood cells.
(05 Mar 2000)
exogenous cycle The portion of a parasitic life cycle occurring outside the host.
(05 Mar 2000)
fatty acid oxidation cycle A series of reactions involving acyl-coenzyme A compounds, whereby these undergo beta oxidation and thioclastic cleavage, with the formation of acetyl-coenzyme A; the major pathway of fatty acid catabolism in living tissue.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • padded cell
    (´ÙÄ¡Áö ¾Ê°Ô º®¿¡ ÆÐµå¸¦ ´í)Á¤½Å º´¿ø ȯÀÚ½Ç
  • photoelectric cell
    ±¤ÀüÁö;±¤Àü°ü 9
  • photoelectrochemical cell
    °í¾ÆÀü±â È­ÇÐ ÀüÁö
  • porous cell(cup)
    Ãʹú±¸ÀÌ Àڱ⠿ë±â
  • primary cell
    1Â÷ ÀüÁö
  • red blood cell(corpuscle)
    ÀûÇ÷±¸
  • red cell
    =REC BLOOD CELL
  • solar battery(cell)
    žç ÀüÁö
  • storage cell
    ÃàÀüÁö;±â¾ï ´ÜÀ§
  • voltaic cell
    ÀüÁö
  • wet cell
    ½ÀÀüÁö
  • point
    Á¡,³¡,¿äÁ¡,Áö½ÃÇÏ´Ù,ÁöÀûÇÏ´Ù
  • point-of-sale
    ¸ÅÀåÀÇ
  • point-of-sales
    ¸ÅÀåÀÇ
  • Curie point (temperature)
    Äû¸®Á¡(¿Âµµ)(Àڱ⠺¯Å°¡ ÀϾ´Â ¿Âµµ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á